Cogent Biosciences reports 65% response rate in mastocytosis trial
Go back to Cogent Biosciences reports 65% response rate in mastocytosis trial| COGENT (NASDAQ: COGT) | Delayed: 35.28 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $35.28 | 52 Week High | $5.57 | |||
| Open | $35.28 | 52 Week Low | $2.90 | |||
| Day High | $35.28 | P/E | 160.36 | |||
| Day Low | $35.28 | EPS | $0.22 | |||
| Volume | 351 | |||||

